The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cancer Diagnostics Market Research Report 2024

Global Cancer Diagnostics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1885773

No of Pages : 79

Synopsis
This report mainly covers cancer diagnostics market. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.
The global Cancer Diagnostics market was valued at US$ 160330 million in 2023 and is anticipated to reach US$ 228200 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
North American market for Cancer Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Diagnostics in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Diagnostics include Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Siemens Healthcare and C.R. Bard, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Diagnostics.
Report Scope
The Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton, Dickinson and Company
GE Healthcare
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Illumina
Siemens Healthcare
C.R. Bard
Segment by Type
Platform-based
Instrument-based
Segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Platform-based
1.2.3 Instrument-based
1.3 Market by Application
1.3.1 Global Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Diagnostics Market Perspective (2019-2030)
2.2 Cancer Diagnostics Growth Trends by Region
2.2.1 Global Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Cancer Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Cancer Diagnostics Market Dynamics
2.3.1 Cancer Diagnostics Industry Trends
2.3.2 Cancer Diagnostics Market Drivers
2.3.3 Cancer Diagnostics Market Challenges
2.3.4 Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Diagnostics Players by Revenue
3.1.1 Global Top Cancer Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Diagnostics Revenue
3.4 Global Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Revenue in 2023
3.5 Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Diagnostics Breakdown Data by Type
4.1 Global Cancer Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Cancer Diagnostics Forecasted Market Size by Type (2025-2030)
5 Cancer Diagnostics Breakdown Data by Application
5.1 Global Cancer Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Cancer Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Diagnostics Market Size (2019-2030)
6.2 North America Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Diagnostics Market Size by Country (2019-2024)
6.4 North America Cancer Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Diagnostics Market Size (2019-2030)
7.2 Europe Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Diagnostics Market Size by Country (2019-2024)
7.4 Europe Cancer Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Diagnostics Market Size (2019-2030)
9.2 Latin America Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Cancer Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton, Dickinson and Company
11.1.1 Becton, Dickinson and Company Company Detail
11.1.2 Becton, Dickinson and Company Business Overview
11.1.3 Becton, Dickinson and Company Cancer Diagnostics Introduction
11.1.4 Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2019-2024)
11.1.5 Becton, Dickinson and Company Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Cancer Diagnostics Introduction
11.2.4 GE Healthcare Revenue in Cancer Diagnostics Business (2019-2024)
11.2.5 GE Healthcare Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Cancer Diagnostics Introduction
11.3.4 Abbott Revenue in Cancer Diagnostics Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Cancer Diagnostics Introduction
11.4.4 Roche Revenue in Cancer Diagnostics Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Cancer Diagnostics Introduction
11.5.4 Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Detail
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Cancer Diagnostics Introduction
11.6.4 Agilent Technologies Revenue in Cancer Diagnostics Business (2019-2024)
11.6.5 Agilent Technologies Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Cancer Diagnostics Introduction
11.7.4 Illumina Revenue in Cancer Diagnostics Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 Siemens Healthcare
11.8.1 Siemens Healthcare Company Detail
11.8.2 Siemens Healthcare Business Overview
11.8.3 Siemens Healthcare Cancer Diagnostics Introduction
11.8.4 Siemens Healthcare Revenue in Cancer Diagnostics Business (2019-2024)
11.8.5 Siemens Healthcare Recent Development
11.9 C.R. Bard
11.9.1 C.R. Bard Company Detail
11.9.2 C.R. Bard Business Overview
11.9.3 C.R. Bard Cancer Diagnostics Introduction
11.9.4 C.R. Bard Revenue in Cancer Diagnostics Business (2019-2024)
11.9.5 C.R. Bard Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’